Search Result for:
Uterine Cancer
Browse:
Education by Topic
New Online Offerings
Certificate Programs
Translated Offerings
Annual Global Meeting
Sort By
This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.
On-Demand
Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations. 
Library
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
On-Demand
Presented during the IGCS and AGOI webinar Uterine Cancers in the Molecular Era: Changing Trends and Implications. Recorded on June 23, 2025.
On-Demand
In this special IGCS podcast episode, we spotlight the United Kingdom’s groundbreaking National Lynch Syndrome Project and its free, globally accessible e-learning modules that equip healthcare professionals with the knowledge and skills to implement genetic testing for Lynch syndrome in gynecologic oncology.
On-Demand
This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.
On-Demand
Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024. 
On-Demand
 This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.
On-Demand
Treatment options for patients with advanced or recurrent endometrial cancers are rapidly evolving. Dr. Vicky Makker shares recent report from ASCO 2024 on Selinexor, a novel oral maintenance therapy for patients with TP53 wild type advanced or recurrent endometrial cancer. 
On-Demand
In this session, we will review new and evolving uterine mesenchymal entities as well as biomarker and molecular assays to aid in these diagnoses.
On-Demand
New trial in progress enrollment information for advanced and recurrent endometrial cancer - Selinexor in Maintenance Therapy After Systemic Therapy for Patients with p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma: XPORT-042.
On-Demand
Listen to Dr. Matthew Powell and Dr. Wendel Naumann discuss the 2024 SGO Annual Meeting on Women’s Cancer late-breaking abstract Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY.
On-Demand
IGCS and Eisai welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to view the first presentation from the An Evolving Frontier - Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers Industry Supported Symposium presented at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.
On-Demand
Hear from Dr. Ramez Eskander as he teaches learners to understand the options to treat mismatch repair deficient endometrial cancer and we will discuss what to consider at the time of recurrence in the setting of prior immunotherapy. 
On-Demand
Didactic presentation recorded in June 2023. 
On-Demand
Dr. Tjalling Bosse reviews why, when, and how to implement molecular classification of endometrial carcinoma. 
On-Demand
Radiation oncologist experts provide advice for patient case on recurrent endometrial cancer presented by Dr. Nanise Sikiti of Fiji.
On-Demand
New drug combinations have emerged for the treatment management of advanced endometrial cancer. Learn the benefits of having your multidisciplinary team involved in the management of toxicities in these patients. 
On-Demand
Webinar recorded live on Thursday, November 10, 2022.
On-Demand
Course 1 to 20 of 26